Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A paralegal recently fired by French drugmaker Sanofi has filed a whistleblower lawsuit, claiming she was discharged after protesting an alleged kickback scheme to increase U.S. sales of its insulin medicines.
The lawsuit, filed in New Jersey Superior Court in Newark by Diane Ponte, accuses Sanofi SA, recently ousted CEO Christopher Viehbacher and more than 10 other executives of paying consultants millions to induce pharmacists to fill prescriptions for generic insulin with Sanofi's brand-name versions, rather than those of rival Novo Nordisk A/S.
In a statement, Sanofi denied firing Ponte for whistleblowing, calling her allegations without merit and saying she's a "disgruntled former employee who is opportunistically attacking our company."
Attempts to contact Viehbacher were unsuccessful.
http://www.poconorecord.com/article/20141206/NEWS/141209486/101010/NEWS
The lawsuit, filed in New Jersey Superior Court in Newark by Diane Ponte, accuses Sanofi SA, recently ousted CEO Christopher Viehbacher and more than 10 other executives of paying consultants millions to induce pharmacists to fill prescriptions for generic insulin with Sanofi's brand-name versions, rather than those of rival Novo Nordisk A/S.
In a statement, Sanofi denied firing Ponte for whistleblowing, calling her allegations without merit and saying she's a "disgruntled former employee who is opportunistically attacking our company."
Attempts to contact Viehbacher were unsuccessful.
http://www.poconorecord.com/article/20141206/NEWS/141209486/101010/NEWS